カリフォルニア州におけるがん(全種類)の臨床試験
カリフォルニア州内の拠点で、がん(全種類)に関する175件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles73件の研究
- Mountain View40件の研究
- San Francisco35件の研究
- Baldwin Park33件の研究
- San Diego32件の研究
- Santa Monica21件の研究
- Irvine16件の研究
- Orange13件の研究
- Santa Rosa11件の研究
- Sacramento11件の研究
- Santa Barbara7件の研究
- Concord7件の研究
- Huntington Beach6件の研究
- Newport Beach6件の研究
- San Jose6件の研究
- Long Beach6件の研究
- Fullerton5件の研究
- Glendale5件の研究
- Vallejo5件の研究
- Oakland5件の研究
- Roseville4件の研究
- Richmond4件の研究
- Fresno4件の研究
- Sunnyvale3件の研究
- Modesto3件の研究
- Mission Viejo3件の研究
- Bakersfield3件の研究
- Pleasanton3件の研究
- Santa Clara3件の研究
公式研究テキスト(英語)
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, La Jolla
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06796907Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- 他10件
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- City of Hope Duarte, Duarte
- University of California at Los Angeles, Santa Monica
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07529808A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Start Los Angeles /ID# 281533, Los Angeles
被験者募集中第2相
18歳以上 · 女性 · 2026/10/01更新 · NCT07024784A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 277005, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 277928, Irvine
- UC San Diego Health - Moores Cancer Center /ID# 278836, La Jolla
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07155187A Study of ASP3082 in Adults With Advanced Solid Tumors
- City of Hope National Medical Center, Duarte
- UCLA Santa Monica Hematology Oncology, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- City of Hope, Duarte
- University of California, Irvine Medical Center - Hematology/Oncology, Orange
- Stanford University School of Medicine, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07192471Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Samsun Clinic - Ridley-Tree Cancer Center, Santa Barbara
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07566156A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
- City of Hope National Medical Center /ID# 280273, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 279067, Irvine
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07409246A Study to Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- City Of Hope Comprehensive Cancer Center /ID# 281939, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07744126uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Providence St. Johns Health Center, Santa Monica
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/29更新 · NCT05874921Registry Study for Radiation Therapy Outcomes
- California Protons Cancer Therapy Center, San Diego
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/29更新 · NCT01255748A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Los Angeles
- PHN-012-001 Site, San Diego
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
- City of Hope Comprehensive Cancer Center, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06884618A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Sansum Clinic, Santa Barbara
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/09/25更新 · NCT05920356Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- 他14件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Children's Hospital Los Angeles ( Site 4006), Los Angeles
被験者募集中第1/2相
1 Month – 17 Years · 全性別 · 2026/09/25更新 · NCT07630974A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- City of Hope, Duarte
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06150157A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- CBCC Global Research - Comprehensive Blood & Cancer Center, Bakersfield
- TOI Clinical Research, Cerritos
- University of California, San Diego Moores Cancer Center, La Jolla
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 1, Duarte
- Quetzal Site 7, Los Angeles
- Quetzal Site 5, Stanford
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458Intratumoral N17350 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
- UCLA - Jonsson Comprehensive Cancer Center, Los Angeles
- Scripps Clinic Torrey Pines - La Jolla, San Diego
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07339176A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- City of Hope National Medical Center /ID# 281322, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 281396, Irvine
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- City of Hope /ID# 243157, Duarte
- City Of Hope - Seacliff /ID# 263143, Huntington Beach
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 263144, Irvine
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT04928846Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Sutter Auburn, Auburn
- Sutter Alta Bates, Berkeley
- The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles
- 他19件
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Prospective Study to Assess a Diagnostic Aid for Cancer
- Southern California Research Center, Coronado
- Palomar Health, Poway
- South Coast Gynecologic Oncology, San Diego
被験者募集中観察研究
45歳以上 · 全性別 · 2026/09/21更新 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- City Of Hope, Duarte
- University Of California San Diego Moores Cancer Center, La Jolla
- University of California, San Francisco- California, San Francisco
- 他2件
被験者募集中第2/3相
全年齢 · 全性別 · 2026/09/18更新 · NCT03435796A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Childrens Hospital Los Angeles ( Site 3006), Los Angeles
被験者募集中第1/2相
1 Month – 17 Years · 全性別 · 2026/09/17更新 · NCT06941272Statins to Prevent Cancer Associated Blood Clots
- City of Hope, Irvine
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07303816RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
- University of California, San Francisco, San Francisco
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/15更新 · NCT06633224(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- City of Hope Comprehensive Cancer Center, Duarte
- UCLA Medical Center, Los Angeles
- Stanford Cancer Institute, Stanford
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT04996875A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Southern California /ID# 272414, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06953960Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
- UC Davis Health, Sacramento
- UC Davis Medical Center, Sacramento
被験者募集中
18歳以上 · 全性別 · 2026/09/11更新 · NCT06722508A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT05123482A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- University of Southern California Norris Comprehensive, Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06634589Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- UCI Health Chao Family Comprehensive Cancer Center, Orange
- Investigational Site Number: 403, Palo Alto
被験者募集中第1相
18歳以上 · 男性 · 2026/09/10更新 · NCT05997615A Phase 1/1b Study of IAM1363 in HER2 Cancers
- UCSD Moores Cancer Center, La Jolla
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06253871Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
- Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale
被験者募集中
70歳以上 · 全性別 · 2026/09/09更新 · NCT07629206ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。